Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10709631 | 0.96 | ALDH1A1 (0.36) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL973368 | 0.87 | — | — | |
| SCHEMBL975868 | 0.85 | — | — | |
| SCHEMBL2967243 | 0.84 | — | — | |
| SCHEMBL58438 | 0.82 | — | — | |
| SCHEMBL6384032 | 0.82 | — | — | |
| SCHEMBL10964225 | 0.82 | — | — | |
| SCHEMBL7719848 | 0.77 | — | — | |
| SCHEMBL1360690 | 0.75 | — | — | |
| SCHEMBL28405447 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219919-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | ORCA HOLDINGS, LLC | 2023-07-13 | — | — | US | disclosed |
| EP-3897971-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | 6th Wave Innovations Corp. (US) | 2021-10-27 | — | — | EP | disclosed |
| CN-113423499-A | Extraction of lithium with crown ethers | 第六波创新公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2020131964-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | 6th Wave Innovations Corp. (US) | 2020-06-25 | — | — | WO | disclosed |
| US-4598073-A | Certain polycyclo-palladium-bipyridine complexes having anti-tumor activity | RESEARCH CORPORATION (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0053389-B1 | PROCESS FOR PREPARING CATIONIC SURFACE ACTIVE AGENTS | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
| US-4385184-A | QUATERNARYL AMMONIUM WITH HYDROXYPHENETHYL GROUP | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-05-24 | — | — | US | disclosed |
| EP-0053389-A1 | Process for preparing cationic surface active agents | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 1982-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219919-A1 | LITHIUM EXTRACTION WITH CROWN ETHERS | LCLAT1, LCT, IGF2R | ALDH1A1 4352/4885TSHR 400/4885MAPK1 3053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.